- Home
- SBH vs DYN Comparison
SBH vs DYN Comparison
Compare SBH & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- DYN
- Stock Information
- Founded
- SBH 1964
- DYN 1984
- Country
- SBH United States
- DYN United States
- Employees
- SBH N/A
- DYN N/A
- Industry
- SBH Other Specialty Stores
- DYN Medicinal Chemicals and Botanical Products
- Sector
- SBH Consumer Discretionary
- DYN Health Care
- Exchange
- SBH Nasdaq
- DYN Nasdaq
- Market Cap
- SBH 814.6M
- DYN 848.8M
- IPO Year
- SBH 2006
- DYN 2020
- Fundamental
- Price
- SBH $8.17
- DYN $11.41
- Analyst Decision
- SBH Buy
- DYN Strong Buy
- Analyst Count
- SBH 6
- DYN 12
- Target Price
- SBH $12.70
- DYN $47.00
- AVG Volume (30 Days)
- SBH 1.9M
- DYN 2.9M
- Earning Date
- SBH 05-12-2025
- DYN 05-08-2025
- Dividend Yield
- SBH N/A
- DYN N/A
- EPS Growth
- SBH 4.93
- DYN N/A
- EPS
- SBH 1.66
- DYN N/A
- Revenue
- SBH $3,723,624,000.00
- DYN N/A
- Revenue This Year
- SBH $1.08
- DYN N/A
- Revenue Next Year
- SBH $1.78
- DYN N/A
- P/E Ratio
- SBH $4.93
- DYN N/A
- Revenue Growth
- SBH 0.57
- DYN N/A
- 52 Week Low
- SBH $7.54
- DYN $6.36
- 52 Week High
- SBH $14.79
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- SBH 48.08
- DYN 55.69
- Support Level
- SBH $7.90
- DYN $9.17
- Resistance Level
- SBH $8.37
- DYN $12.47
- Average True Range (ATR)
- SBH 0.30
- DYN 0.96
- MACD
- SBH 0.06
- DYN 0.13
- Stochastic Oscillator
- SBH 49.06
- DYN 67.88
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.